Brief: DSS's Impact Biomedical Announces Second US Patent Issued For Its Proprietary Equivir Compound
12/07/2021 13:14
July 12 (Reuters) - Document Security Systems Inc DSS.A :
* DSS'S IMPACT BIOMEDICAL ANNOUNCES SECOND US PATENT ISSUED
FOR
ITS PROPRIETARY EQUIVIR COMPOUND
Source text for Eikon: ID:nGNX6tXThd
Further company coverage: DSS.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on DSS
See all newsBrief: Dss Withdraws S-1 Registration Statement With SEC
Brief: Dss Reports Going Concern Audit Opinion In 2025 10-K Filing
Brief: Dss Inc Actively Evaluating Acquisition Opportunities Within Folding Carton Space
Brief: Dss, Inc. Announces Pricing Of $1.0 Million Underwritten Public Offering
Brief: DSS’s Subsidiary, Impact Biomedical, Announces Strategic Merger